As Fisher notes, this shift represents a rare alignment between public health goals and commercial opportunity. The GLP-1 Economy: From Pharma to Food According to Grand View Research, the global GLP-1 market now tops $53 billion , growing at 17% annually
L., Goldberg, R., Abitbol, C., Monkus, E., and Strauss, J
Presented in liquid form in single-dose vials
Research examining metabolic benefits of GLP-1 receptor agonists in patients with coexisting type 2 diabetes and autoimmune thyroid disease has shown that these medications remain effective for glycemic control and weight management in this population
Ro, Hims & Midi The GLP-1 economy now divides direct-to-consumer platforms (Ro, Hims) built for customer acquisition and prescription throughput from emerging care platforms (Knownwell, Midi) built for insurer acceptance and longitudinal management